Zaleplon displays a selectivity to recombinant GABAA receptors different from zolpidem, zopiclone and benzodiazepines

Neuroscience Research Communications

Volumn 25, Issue 3, 1999, Pages 139-148

  Dämgen, Kerstin ^a   Lüddens, Hartmut ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Lorazepam; Recombinant GGABAA receptors; Ro15 4513; Zaleplon; Zolpidem; Zopiclone

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE; LORAZEPAM; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; RECEPTOR AFFINITY; TRANQUILIZING ACTIVITY;

EID: 0033386952     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1520-6769(199911/12)25:3<139::aid-nrc3>3.0.co;2-w     Document Type: Article

References (26)

1. Allen D, Curran HV and Lader M. The effects of single doses of CL284,846, lorazepam, and placebo on psychomotor and memory function in normal male volunteers. Eur J Clin Pharmacol 1993;45:313-320.
2. Appleton R, Sweeney A, Choonara I, Robson J and Molyneux E. Lorazepam versus diazepam in the acute treatment of epileptic seizures and status epilepticus. Dev Med Child Neurol 1995;37:682-688.
3. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.
4. Day IP, Clody DE, Monaghan MM, Abel MS, Duza JP and Beer B. Pharmacology of CL284846, a non-benzodiazepine sedative with reduced amnestic liability. Soc Neurosci Abstr 1992;18:725.
5. Eichinger A and Sieghart W. Photoaffinity labeling of different benzodiazepine receptors at physiological temperature. J Neurochem 1984;43:1745-1748.
6. Gavish M and Snyder SH. Benzodiazepine recognition sites on GABA receptors. Nature 1980;287:651-652.
7. Gluckman MI and Stein L. Pharmacology of lorazepam. J Clin Psychiatry 1978;39:3-10.
8. Griebel G, Sanger DJ and Perrault G. The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 1996;124:245-254.
9. Hebebrand J, Friedl W, Unverzagt B and Propping P. Benzodiazepine receptor subunits in avian brain. J Neurochem 1986;47:790-793.
10. A channel subtypes. Mol Neurobiol 1998;18:35-86.
11. 3H-diazepam binding to art brain membranes. Eur J Pharmac 1978;49:323-326.
12. Lo MM, Niehoff DL, Kuhar MJ and Snyder SH. Autoradiographic differentiation of multiple benzodiazepine receptors by detergent solubilization and pharmacologic specificity. Neurosci Lett 1983;39:37-44.
13. Lüddens H and Korpi ER. Methods for Transient Expression of Hetero-Oligomeric Ligand-Gated Ion Channels. In: Challiss RAJ, editor. Methods in Molecular Biology. Vol.: 83. Totowa, NJ, USA: Humana Press Inc.; 1997. p 55-63.
14. A receptor selective for a behavioural alcohol antagonist. Nature 1990;346:648-651.
15. Lüddens H, Seeburg PH and Korpi ER. Impact of β and γ variants on ligand-binding properties of γ-aminobutyric acid type A receptors. Mol Pharmacol 1994;45:810-814.
16. A-benzodiazepine receptors produced in transfected cells. Science 1989;245:1389-1392.
17. Pritchett DB and Seeburg PH. γ-Aminobutyric acid type A receptor point mutation increases the affinity of compounds for the benzodiazepine site. Proc Natl Acad Sci USA 1991;88:1421-1425.
18. 5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 1990;54:1802-1804.
19. Sanger DJ, Morel E and Perrault G. Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmacol 1996;313:35-42.
20. Sieghart W. Benzodiazepine receptors: multiple receptors or multiple conformations? J Neural Transm 1985;63:191-208.
21. Sieghart W and Karobath M. Molecular heterogeneity of benzodiazepine receptors. Nature 1980;286:285-287.
22. Sigel E and Barnard EA. A γ-aminobutyric acid/benzodiazepine receptor complex from bovine cerebral cortex. Improved purification with preservation of regulatory sites and their interactions. J Biol Chem 1984;259:7219-23.
23. Tallman JF, Thomas JW and Gallager DW. GABAergic modulation of benzodiazepine binding site sensitivity. Nature 1978;288:609-610.
24. Vanover KE and Barrett JE. Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846. Psychopharmacology Bed 1994;115:289-296.
25. Vidailhet P, Kazes M, Danion JM, Kauffmann-Muller F and Grange D. Effects of lorazepam and diazepam on conscious and automatic memory processes. Psychopharmacology 1996;127:63-72.
26. Wetzel H, Heuser I and Benkert O. Stupor and affective state: alleviation of psychomotor disturbances by lorazepam and recurrence of symptoms after Ro 15-1788. J Nerv Ment Dis 1987;175:240-242.